The Absence of HIF-1α Increases Susceptibility to Leishmania donovani Infection via Activation of BNIP3/mTOR/SREBP-1c Axis
Inês Mesquita,
Carolina Ferreira,
Diana Moreira,
George Eduardo Gabriel Kluck,
Ana Margarida Barbosa,
Egídio Torrado,
Ricardo Jorge Dinis-Oliveira,
Luís Gafeira Gonçalves,
Charles-Joly Beauparlant,
Arnaud Droit,
Luciana Berod,
Tim Sparwasser,
Neelam Bodhale,
Bhaskar Saha,
Fernando Rodrigues,
Cristina Cunha,
Agostinho Carvalho,
António Gil Castro,
Jérôme Estaquier,
Ricardo Silvestre
Affiliations
Inês Mesquita
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
Carolina Ferreira
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
Diana Moreira
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
George Eduardo Gabriel Kluck
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal; Laboratory of Lipid and Lipoprotein Biochemistry, Medical Biochemistry Institute, Federal University of Rio de Janeiro, 21941-901 Rio de Janeiro, Brazil
Ana Margarida Barbosa
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
Egídio Torrado
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
Ricardo Jorge Dinis-Oliveira
Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal; Department of Sciences, IINFACTS–Institute of Research and Advanced Training in Health Sciences and Technologies, University Institute of Health Sciences (IUCS), CESPU, CRL, 4585-116 Gandra, Portugal; UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
Luís Gafeira Gonçalves
Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, 2780-157 Oeiras, Portugal
Charles-Joly Beauparlant
Département de Médecine Moléculaire–Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada; Centre de Recherche du CHU de Québec–Université Laval, Québec, QC G1V 4G2, Canada
Arnaud Droit
Département de Médecine Moléculaire–Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada; Centre de Recherche du CHU de Québec–Université Laval, Québec, QC G1V 4G2, Canada
Luciana Berod
Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Niedersachsen 30625, Germany
Tim Sparwasser
Department of Medical Microbiology and Hygiene, Medical Center of the Johannes Gutenberg-University of Mainz, Obere Zahlbacherstrasse, 6755131 Mainz, Germany
Neelam Bodhale
National Centre for Cell Science, 411007 Pune, India
Bhaskar Saha
National Centre for Cell Science, 411007 Pune, India; Case Western Reserve University, Cleveland, OH 44106, USA; Trident Academy of Creative Technology, 751024 Bhubaneswar, Odisha, India
Fernando Rodrigues
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
Cristina Cunha
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
Agostinho Carvalho
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
António Gil Castro
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal
Jérôme Estaquier
Centre de Recherche du CHU de Québec–Université Laval, Québec, QC G1V 4G2, Canada; INSERM U1124, Université de Paris, 75006 Paris, France; Corresponding author
Ricardo Silvestre
Microbiology and Infection Research Domain (MIRD), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal; ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal; Corresponding author
Summary: Hypoxia-inducible factor-1 alpha (HIF-1α) is considered a global regulator of cellular metabolism and innate immune cell functions. Intracellular pathogens such as Leishmania have been reported to manipulate host cell metabolism. Herein, we demonstrate that myeloid cells from myeloid-restricted HIF-1α-deficient mice and individuals with loss-of-function HIF1A gene polymorphisms are more susceptible to L. donovani infection through increased lipogenesis. Absence of HIF-1α leads to a defect in BNIP3 expression, resulting in the activation of mTOR and nuclear translocation of SREBP-1c. We observed the induction of lipogenic gene transcripts, such as FASN, and lipid accumulation in infected HIF-1α−/− macrophages. L. donovani-infected HIF-1α-deficient mice develop hypertriglyceridemia and lipid accumulation in splenic and hepatic myeloid cells. Most importantly, our data demonstrate that manipulating FASN or SREBP-1c using pharmacological inhibitors significantly reduced parasite burden. As such, genetic deficiency of HIF-1α is associated with increased lipid accumulation, which results in impaired host-protective anti-leishmanial functions of myeloid cells. : Mesquita et al. show that genetic deficiency of HIF-1α in the myeloid compartment promotes de novo lipogenesis through the BNIP3/mTOR/SREBP-1c axis. This is associated with higher susceptibility to Leishmania donovani infection, which is reduced upon pharmacological inhibition of fatty acid synthesis. Keywords: HIF-1α, visceral leishmaniasis, macrophages, lipogenesis, SREBP-1c, FASN, acetate, myeloid cells